Aurinia Early Urinary Protein Reduction Predicts Response

Summary

An exploratory study assessing the ability of biomarkers measured at 8 weeks to predict clinical response over 24 and 48 weeks in subjects taking voclosporin 23.7 mg twice daily (BID) in combination with standard of care in patients with active lupus nephritis

Timeline

Start

2015-06

Primary completion

2016-12

Completion

2017-02-17

Drugs

Indications